Help | RSS Feed



Oncternal Therapeutics, Inc. (NASD:ONCT) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Oncternal Therapeutics, Inc. (NASD:ONCT) seasonal charts above shows that a Buy Date of December 28 and a Sell Date of May 15 has resulted in a geometric average return of 3.7% above the benchmark rate of the S&P 500 Total Return Index over the past 15 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 15 years by an average of 40.2% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with large unmet medical need. Its product pipeline include Cirmtuzumab, TK216 and ROR1 CAR-T.

To download ONCT seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore